Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Onyx Pharmaceuticals, Inc. (ONXX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Onyx Pharmaceuticals is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company’s clinical pipeline includes Nexavar® for treatment of liver, kidney, thyroid and breast cancer; Kyprolis™ for multiple myeloma, solid tumor and hematologic malignancies; and Regorafenib, for colorectoral cancer and gist. For more information visit the company’s Web site at www.onyx-pharm.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below:

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *